(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid

C25H35ClF3N7O4 — CID 159778233

IUPAC(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid
SMILESCC(C)(C)NC(=O)[C@H]1CN(C2CCN(c3n[nH]c(N)n3)CC2)[C@@H](Cc2ccc(Cl)cc2)CO1.O=C(O)C(F)(F)F
InChIInChI=1S/C23H34ClN7O2.C2HF3O2/c1-23(2,3)27-20(32)19-13-31(18(14-33-19)12-15-4-6-16(24)7-5-15)17-8-10-30(11-9-17)22-26-21(25)28-29-22;3-2(4,5)1(6)7/h4-7,17-19H,8-14H2,1-3H3,(H,27,32)(H3,25,26,28,29);(H,6,7)/t18-,19+;/m0./s1
InChIKeyNIPCKAKLSOPMNY-GRTNUQQKSA-N
MW590.05 g/mol
LogP2.87
Rot. Bonds5

About (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid

(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid (PubChem CID 159778233) has the molecular formula C25H35ClF3N7O4 and a molecular weight of 590.05 g/mol. Its IUPAC name is (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid
PubChem CID159778233
Molecular FormulaC25H35ClF3N7O4
Molecular Weight590.05 g/mol
Exact Mass589.24
IUPAC Name(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid
SMILESCC(C)(C)NC(=O)[C@H]1CN(C2CCN(c3n[nH]c(N)n3)CC2)[C@@H](Cc2ccc(Cl)cc2)CO1.O=C(O)C(F)(F)F
InChIInChI=1S/C23H34ClN7O2.C2HF3O2/c1-23(2,3)27-20(32)19-13-31(18(14-33-19)12-15-4-6-16(24)7-5-15)17-8-10-30(11-9-17)22-26-21(25)28-29-22;3-2(4,5)1(6)7/h4-7,17-19H,8-14H2,1-3H3,(H,27,32)(H3,25,26,28,29);(H,6,7)/t18-,19+;/m0./s1
InChIKeyNIPCKAKLSOPMNY-GRTNUQQKSA-N
XLogP2.87
TPSA149.70 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500590.05
LogP ≤ 52.87
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid?
The IUPAC name of (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid (CID 159778233) is (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid.
What is the SMILES notation for (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid?
The canonical SMILES for (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid is CC(C)(C)NC(=O)[C@H]1CN(C2CCN(c3n[nH]c(N)n3)CC2)[C@@H](Cc2ccc(Cl)cc2)CO1.O=C(O)C(F)(F)F.
What is the InChIKey of (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid?
The InChIKey is NIPCKAKLSOPMNY-GRTNUQQKSA-N. The full InChI is InChI=1S/C23H34ClN7O2.C2HF3O2/c1-23(2,3)27-20(32)19-13-31(18(14-33-19)12-15-4-6-16(24)7-5-15)17-8-10-30(11-9-17)22-26-21(25)28-29-22;3-2(4,5)1(6)7/h4-7,17-19H,8-14H2,1-3H3,(H,27,32)(H3,25,26,28,29);(H,6,7)/t18-,19+;/m0./s1.
What are the key properties of (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid?
(2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid has a molecular weight of 590.05 g/mol, XLogP of 2.87, 5 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,5S)-4-[1-(5-amino-1H-1,2,4-triazol-3-yl)piperidin-4-yl]-N-tert-butyl-5-[(4-chlorophenyl)methyl]morpholine-2-carboxamide;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 159778233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).